Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Alzheimer's Disease

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 13 articles:
HTML format
Text format

Single Articles

    September 2019
  1. KEUSS SE, Bowen J, Schott JM
    Looking beyond the eyes: visual impairment in posterior cortical atrophy.
    Lancet. 2019;394:1055.
    PubMed     Text format    

    August 2019
  2. BAKHTA K, Cecillon E, Lacombe E, Lamy M, et al
    Alzheimer's disease and neurodegenerative diseases in France.
    Lancet. 2019;394:466-467.
    PubMed     Text format    

    April 2019
    Alzheimer's disease.
    Lancet. 2019;393:1589.
    PubMed     Text format    

    January 2019
  4. SCHOTT JM, Aisen PS, Cummings JL, Howard RJ, et al
    Unsuccessful trials of therapies for Alzheimer's disease.
    Lancet. 2019;393:29.
    PubMed     Text format    

  5. ANDERSON RM, Hadjichrysanthou C, Evans S, McRae-McKee K, et al
    Unsuccessful trials of therapies for Alzheimer's disease - Authors' reply.
    Lancet. 2019;393:29-30.
    PubMed     Text format    

    June 2018
  6. BURKI T
    Alzheimer's disease research: the future of BACE inhibitors.
    Lancet. 2018;391:2486.
    PubMed     Text format    

    February 2018
  7. WATTS G
    Prospects for dementia research.
    Lancet. 2018;391:416.
    PubMed     Text format    

    November 2017
  8. ANDERSON RM, Hadjichrysanthou C, Evans S, Wong MM, et al
    Why do so many clinical trials of therapies for Alzheimer's disease fail?
    Lancet. 2017;390:2327-2329.
    PubMed     Text format    

    December 2016
    Alzheimer's disease: expedition into the unknown.
    Lancet. 2016;388:2713.
    PubMed     Text format    

    November 2016
  10. GAUTHIER S, Feldman HH, Schneider LS, Wilcock GK, et al
    Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.
    Lancet. 2016 Nov 15. pii: S0140-6736(16)31275.
    PubMed     Text format     Abstract available

  11. RAFII MS
    Targeting tau protein in Alzheimer's disease.
    Lancet. 2016 Nov 15. pii: S0140-6736(16)32107.
    PubMed     Text format    

  12. SNYDER A
    Allen Roses.
    Lancet. 2016;388:2232.
    PubMed     Text format    

    August 2016
    Reduce vascular risk to prevent dementia?
    Lancet. 2016;388:738-40.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.